Media stories about UnitedHealth Group (NYSE:UNH) have trended somewhat positive recently, Accern reports. The research firm ranks the sentiment of news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. UnitedHealth Group earned a daily sentiment score of 0.13 on Accern’s scale. Accern also gave media coverage about the healthcare conglomerate an impact score of 46.5643837661604 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
These are some of the headlines that may have effected Accern Sentiment’s scoring:
- Sumitomo Mitsui Trust Holdings, Inc. Marginally Raises Its Holdings in UnitedHealth Group Incorporated (UNH) Stock … - Modern Readers (modernreaders.com)
- Wounded Veterans to Cycle 500-Plus Miles from Minneapolis to Chicago During UnitedHealthcare Great Lakes Challenge (finance.yahoo.com)
- UnitedHealth Group Names Two New Directors (finance.yahoo.com)
- Analyzing WellCare Health Plans (WCG) and UnitedHealth Group (UNH) (americanbankingnews.com)
- $50.31 Billion in Sales Expected for UnitedHealth Group Incorporated (UNH) This Quarter (americanbankingnews.com)
A number of analysts have recently commented on the stock. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $215.00 price target for the company in a research note on Tuesday, August 1st. Oppenheimer Holdings, Inc. reiterated an “outperform” rating and issued a $205.00 price target (up from $203.00) on shares of UnitedHealth Group in a research note on Friday, July 21st. Sanford C. Bernstein reiterated an “outperform” rating and issued a $210.00 price target (up from $190.00) on shares of UnitedHealth Group in a research note on Saturday, July 22nd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $208.00 price target on shares of UnitedHealth Group in a research note on Friday, July 21st. Finally, Royal Bank Of Canada reiterated a “buy” rating and issued a $212.00 price target on shares of UnitedHealth Group in a research note on Thursday, July 20th. One equities research analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $200.24.
UnitedHealth Group (NYSE:UNH) traded down 0.04% during trading on Wednesday, hitting $194.83. 2,125,851 shares of the stock traded hands. The stock has a market cap of $191.91 billion, a P/E ratio of 23.41 and a beta of 0.64. The stock has a 50 day moving average price of $187.91 and a 200-day moving average price of $173.50. UnitedHealth Group has a 52-week low of $132.39 and a 52-week high of $196.04.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping the consensus estimate of $2.38 by $0.08. The firm had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The firm’s revenue was up 7.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.96 earnings per share. On average, analysts anticipate that UnitedHealth Group will post $9.87 EPS for the current fiscal year.
In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total value of $990,219.60. Following the completion of the sale, the director now owns 60,516 shares in the company, valued at $10,816,629.84. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the completion of the sale, the director now owns 76,058 shares of the company’s stock, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,540 shares of company stock valued at $2,873,320. 0.89% of the stock is owned by company insiders.
COPYRIGHT VIOLATION NOTICE: This piece of content was posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this piece of content on another website, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The correct version of this piece of content can be accessed at https://stocknewstimes.com/2017/08/09/somewhat-positive-media-coverage-somewhat-unlikely-to-affect-unitedhealth-group-nyseunh-share-price.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.
